z-logo
open-access-imgOpen Access
Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae
Author(s) -
Evangelos J. GiamarellosBourboulis,
Vassiliki Tziortzioti,
Pantelis Koutoukas,
Fotini Baziaka,
Maria Raftogiannis,
Anastasia Antonopoulou,
Theodoros Adamis,
Labros Sabracos,
Helen Giamarellou
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl084
Subject(s) - amikacin , clarithromycin , spleen , klebsiella pneumoniae , medicine , group b , group a , mesenteric lymph nodes , in vivo , gastroenterology , pharmacology , antibiotics , immunology , microbiology and biotechnology , biology , helicobacter pylori , escherichia coli , biochemistry , gene
To apply clarithromycin as an immunomodulatory treatment in experimental infection caused by pan-resistant Klebsiella pneumoniae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom